Cytosorbents Retained Earnings (Accumulated Deficit) 2010-2025 | CTSO
Cytosorbents retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Cytosorbents Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-304 |
| 2023 | $-283 |
| 2022 | $-254 |
| 2021 | $-221 |
| 2020 | $-197 |
| 2019 | $-189 |
| 2018 | $-170 |
| 2017 | $-152 |
| 2016 | $-144 |
| 2015 | $-133 |
| 2014 | $-124 |
| 2013 | $-106 |
| 2012 | $-99 |
| 2011 | $-93 |
| 2010 | $-84 |
| 2009 | $-79 |
| Cytosorbents Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-304 |
| 2025-03-31 | $-305 |
| 2024-12-31 | $-304 |
| 2024-09-30 | $-295 |
| 2024-06-30 | $-293 |
| 2024-03-31 | $-289 |
| 2023-12-31 | $-283 |
| 2023-09-30 | $-277 |
| 2023-06-30 | $-267 |
| 2023-03-31 | $-261 |
| 2022-12-31 | $-254 |
| 2022-09-30 | $-253 |
| 2022-06-30 | $-241 |
| 2022-03-31 | $-230 |
| 2021-12-31 | $-221 |
| 2021-09-30 | $-212 |
| 2021-06-30 | $-205 |
| 2021-03-31 | $-201 |
| 2020-12-31 | $-197 |
| 2020-09-30 | $-196 |
| 2020-06-30 | $-195 |
| 2020-03-31 | $-192 |
| 2019-12-31 | $-189 |
| 2019-09-30 | $-185 |
| 2019-06-30 | $-178 |
| 2019-03-31 | $-174 |
| 2018-12-31 | $-170 |
| 2018-09-30 | $-164 |
| 2018-06-30 | $-161 |
| 2018-03-31 | $-155 |
| 2017-12-31 | $-152 |
| 2017-09-30 | $-149 |
| 2017-06-30 | $-147 |
| 2017-03-31 | $-146 |
| 2016-12-31 | $-144 |
| 2016-09-30 | $-140 |
| 2016-06-30 | $-137 |
| 2016-03-31 | $-134 |
| 2015-12-31 | $-133 |
| 2015-09-30 | $-131 |
| 2015-06-30 | $-128 |
| 2015-03-31 | $-129 |
| 2014-12-31 | $-124 |
| 2014-09-30 | $-114 |
| 2014-06-30 | $-111 |
| 2014-03-31 | $-108 |
| 2013-12-31 | $-106 |
| 2013-09-30 | $-104 |
| 2013-06-30 | $-103 |
| 2013-03-31 | $-101 |
| 2012-12-31 | $-99 |
| 2012-09-30 | $-98 |
| 2012-06-30 | $-96 |
| 2012-03-31 | $-95 |
| 2011-12-31 | $-93 |
| 2011-09-30 | $-91 |
| 2011-06-30 | $-88 |
| 2011-03-31 | $-86 |
| 2010-12-31 | $-84 |
| 2010-09-30 | $-83 |
| 2010-06-30 | $-82 |
| 2010-03-31 | $-81 |
| 2009-12-31 | $-79 |
| 2009-09-30 | $-78 |
| 2009-06-30 | $-77 |
| 2009-03-31 | $-76 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.057B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.767B | 27.06 |
| Boston Scientific (BSX) | United States | $157.318B | 37.52 |
| Stryker (SYK) | United States | $150.713B | 30.68 |
| EssilorLuxottica (ESLOY) | France | $147.808B | 0.00 |
| Medtronic (MDT) | Ireland | $118.836B | 16.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.610B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.040B | 25.18 |
| ResMed (RMD) | United States | $43.006B | 30.76 |
| Agilent Technologies (A) | United States | $34.551B | 22.52 |
| GE HealthCare Technologies (GEHC) | United States | $34.343B | 16.14 |
| Terumo (TRUMY) | Japan | $27.701B | 32.83 |
| Koninklijke Philips (PHG) | Netherlands | $27.289B | 18.05 |
| Insulet (PODD) | United States | $23.284B | 78.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.337B | 13.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.420B | 0.00 |
| Baxter (BAX) | United States | $12.604B | 9.74 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.222B | 30.20 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.958B | 10.70 |
| Envista Holdings (NVST) | United States | $3.609B | 25.26 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.369B | 8.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.283B | 14.57 |
| ICU Medical (ICUI) | United States | $3.164B | 21.54 |
| Haemonetics (HAE) | United States | $2.716B | 12.12 |
| LeMaitre Vascular (LMAT) | United States | $2.271B | 48.70 |
| Acuren (TIC) | United States | $2.108B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.894B | 11.92 |
| Curaleaf Holdings (CURLF) | Canada | $1.891B | 0.00 |
| AtriCure (ATRC) | United States | $1.872B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.757B | 75.46 |
| Phibro Animal Health (PAHC) | United States | $1.316B | 16.82 |
| AdaptHealth (AHCO) | United States | $1.300B | 18.48 |
| Tilray Brands (TLRY) | Canada | $1.266B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.241B | 2591.00 |
| Neogen (NEOG) | United States | $1.225B | 19.45 |
| Valneva SE (VALN) | France | $0.990B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.954B | 0.00 |
| InMode (INMD) | Israel | $0.936B | 8.66 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.626B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.607B | 0.00 |
| SNDL (SNDL) | Canada | $0.591B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.561B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.532B | 0.00 |
| Evolus (EOLS) | United States | $0.497B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.482B | 16.60 |
| CeriBell (CBLL) | United States | $0.442B | 0.00 |
| Owens & Minor (OMI) | United States | $0.390B | 3.46 |
| Sanuwave Health (SNWV) | United States | $0.386B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.306B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.299B | 0.00 |
| High Tide (HITI) | Canada | $0.290B | 0.00 |
| Brainsway (BWAY) | Israel | $0.287B | 58.46 |
| Viemed Healthcare (VMD) | United States | $0.284B | 21.50 |
| Aurora Cannabis (ACB) | Canada | $0.282B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.252B | 0.00 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Quanterix (QTRX) | United States | $0.224B | 0.00 |
| Exagen (XGN) | United States | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.214B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.30 |
| FitLife Brands (FTLF) | United States | $0.160B | 0.00 |
| Biote (BTMD) | United States | $0.159B | 5.28 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.113B | 0.00 |
| MacroGenics (MGNX) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.19 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.07 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.83 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |